Rubinstein Julie

President And COO | President

1 company

Excellent

Trades Analyzed

12M Win Rate

90.5%

Avg 3M Return

+37.2%

Avg 12M Return

+56.3%

Rubinstein Julie is a President And COO at Adaptive Biotechnologies Corporation. Recent SEC Form 4 filings include 0 buys and 32 sells.

Estimated insider holdings value: $5.2M based on current market prices.

Holdings by Company

ADPTApr 27, 2026

Current Shares377.8K

Value$5.17M

Net Activity-2,245,925

Bought: 0Sold: 2.25M

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 27, 2026	ADPT Adaptive Biotechnologies Corporation	President And COO	Sale+OE	19,037	$14.23	$270,896.51	-4.8%	-	-
Apr 24, 2026	ADPT Adaptive Biotechnologies Corporation	President And COO	Sale+OE	57,180	$13.96	$798,423.40	-4.7%	-	-
Apr 21, 2026	ADPT Adaptive Biotechnologies Corporation	President And COO	Sale+OE	69,061	$14.60	$1,008,622.26	-5.4%	-	-
Apr 16, 2026	ADPT Adaptive Biotechnologies Corporation	President And COO	Sale+OE	57,180	$14.45	$826,251.00	-4.4%	-	-
Apr 13, 2026	ADPT Adaptive Biotechnologies Corporation	President And COO	Sale+OE	57,180	$13.26	$758,108.34	-2.2%	-	-
Apr 8, 2026	ADPT Adaptive Biotechnologies Corporation	President And COO	Sale+OE	69,061	$14.34	$990,503.43	-3.8%	-	-
Apr 2, 2026	ADPT Adaptive Biotechnologies Corporation	President And COO	Sale+OE	38,120	$14.53	$553,693.00	-4.1%	-	-
Mar 31, 2026	ADPT Adaptive Biotechnologies Corporation	President And COO	Sale+OE	57,180	$13.14	$751,302.98	-3.0%	-	-
Mar 26, 2026	ADPT Adaptive Biotechnologies Corporation	President And COO	Sale+OE	57,180	$14.03	$802,235.40	-3.9%	-	-
Mar 23, 2026	ADPT Adaptive Biotechnologies Corporation	President And COO	Sale+OE	57,180	$13.46	$769,642.80	-3.8%	-	-